Avricore Health Inc is making waves on the TSX Venture Exchange with a notable 9.09% surge in stock price, reaching CA$0.06.
In a recent trading session, Avricore Health Inc (AVCR.V) saw its stock price rise by 9.09%, reflecting investor enthusiasm and potential growth prospects. With a market cap of approximately CA$7.58 million, this increase could signal a positive shift in market sentiment towards the company.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$6.95M
52W high
$0.10
52W low
$0.04
1W change
-7.69%
Beta
0.32
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
129.7%
Annualized
90-Day Vol
111.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 – C$0.09 |
| 60 trading days | C$0.05 | C$0.03 – C$0.10 |
| 90 trading days | C$0.05 | C$0.02 – C$0.11 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the implications of Avricore's recent financing efforts and expansion plans as potential catalysts for future growth.
Avricore Health Inc's stock rises 9.09% in a single day.
The stock closed at CA$0.06, showing growing investor confidence amidst ongoing expansion efforts.
Bull case
Avricore's recent financing initiatives are aimed at supporting its expansion into the UK market. This funding could provide the company with the capital needed to enhance operations and increase revenue streams.
Bear case
Despite the positive price movement, the company still faces challenges, including a lack of profitability and no recent news, which could lead to volatility in stock performance moving forward.
Recent Financing Initiatives
Avricore Health recently closed a financing round, raising CA$1.254 million to support its expansion plans. This capital injection is crucial for the company's HealthTab™ network, which aims to improve healthcare access through community pharmacies. Such initiatives could drive future revenue growth and attract investor interest.
Market Reaction and Future Outlook
The stock's 9.09% increase indicates a positive market reaction to Avricore's strategic moves. However, investors should remain cautious due to the company's current lack of profitability. Keeping an eye on upcoming developments, especially in the UK market, will be essential for assessing the stock's long-term potential. For more insights, check out the latest on Avricore Health's performance.
Advertisement
